314 results on '"Lasarte, Juan José"'
Search Results
2. Plasma fractalkine contributes to systemic myeloid diversity and PD‐L1/PD‐1 blockade in lung cancer
3. Local delivery of optimized nanobodies targeting the PD-1/PD-L1 axis with a self-amplifying RNA viral vector induces potent antitumor responses
4. The transcriptional regulator Sin3A balances IL‐17A and Foxp3 expression in primary CD4 T cells
5. DNA electroporation in a vacuum: A “shocking” innovation for vaccines
6. Impact of tumor microenvironment on adoptive T cell transfer activity
7. Therapeutic Effect of Irreversible Electroporation in Combination with Poly-ICLC Adjuvant in Preclinical Models of Hepatocellular Carcinoma
8. Regulatory T Cell Inhibition by P60 Combined with Adenoviral AFP Transduced Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma
9. POSTER: CT-342 Prolonged Hematologic Toxicity After B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor (CAR) T-Cell Treatment: From Clinical Data to Ex-Vivo Studies at a Single Center
10. CT-342 Prolonged Hematologic Toxicity After B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor (CAR) T-Cell Treatment: From Clinical Data to Ex-Vivo Studies at a Single Center
11. Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression
12. Targeting FOXP3 Tumor-Intrinsic Effects Using Adenoviral Vectors in Experimental Breast Cancer
13. Targeting Foxp3 Tumor Intrinsic Effects Using Adenoviral Vectors in Experimental Breast Cancer
14. Improvement of cognitive function in wild-type and Alzheimer´s disease mouse models by the immunomodulatory properties of menthol inhalation or by depletion of T regulatory cells
15. Supplemental Appendix from Immunostimulatory Monoclonal Antibodies and Immunomodulation: Harvesting the Crop
16. Data from Immunostimulatory Monoclonal Antibodies and Immunomodulation: Harvesting the Crop
17. Data from Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors
18. Supplementary Figures 1-8, Table 1 from Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors
19. Abstract OT2-10-04: Treatment of advanced or metastatic triple-negative breast cancer with adoptive therapy of PD1+ tumor-infiltrating lymphocytes (TILS001 trial)
20. Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies
21. Targeting inhibition of Foxp3 by a CD28 2′-Fluro oligonucleotide aptamer conjugated to P60-peptide enhances active cancer immunotherapy
22. Therapeutic blockade of Foxp3 in experimental breast cancer models
23. Irreversible electroporation: present and future in the treatment of hepatocellular carcinoma
24. Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination
25. Intratumoral electroporation of a self-amplifying RNA expressing IL-12 induces antitumor effects in mouse models of cancer
26. CD137/CD137 Ligand in Tumor and Viral Immunotherapy
27. Potent clinical predictive and systemic adjuvant therapeutic value of plasma fractalkine in PD-L1/PD-1 blockade immunotherapy for lung cancer
28. BCMA CAR-T Cell Phenotype and Functionality Is Affected By Disease Stage of Multiple Myeloma Patients
29. Identification of Molecular Mechanisms Governing CAR-T Cell Response in MM Patients Using Single Cell Transcriptomics
30. Inhibiting Histone and DNA Methylation Improves Cancer Vaccination in an Experimental Model of Melanoma
31. Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy
32. The transcriptional regulator Sin3A balances IL-17A and Foxp3 expression in primary CD4 T cells
33. CAR-T Cells for the Treatment of Lung Cancer
34. TCR-induced FOXP3 expression by CD8+ T cells impairs their anti-tumor activity
35. The vaccine adjuvant extra domain A from fibronectin retains its proinflammatory properties when expressed in tobacco chloroplasts
36. Therapeutic effect of a peptide inhibitor of TGF-β on pulmonary fibrosis
37. Modulation of Vaccine-Induced Immune Responses to Hepatitis C Virus in Rhesus Macaques by Altering Priming before Adenovirus Boosting
38. Olfactory Characterization and Training in Older Adults: Protocol Study
39. The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?
40. Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential
41. Engineered promiscuous T helper peptides for the induction of immune responses
42. Searching for Peptide Inhibitors of T Regulatory Cell Activity by Targeting Specific Domains of FOXP3 Transcription Factor
43. Intratumoral STING Agonist Injection Combined with Irreversible Electroporation Delays Tumor Growth in a Model of Hepatocarcinoma
44. CO023 - SEGUIMIENTO IN VIVO DE CÉLULAS CAR-T RADIOMARCADAS CON 111IN-OXINA EN UN MODELO TUMORAL DE INMUNOTERAPIA MEDIANTE TRANSFERENCIA CELULAR ADOPTIVA E IMAGEN DUAL SIMULTÁNEA MICROPET-18FDG/111IN-SPECT
45. Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin
46. Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells
47. Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses against Hepatocellular Carcinoma
48. Id1 and PD-1 Combined Blockade Impairs Tumor Growth and Survival of KRAS-mutant Lung Cancer by Stimulating PD-L1 Expression and Tumor Infiltrating CD8+ T Cells
49. Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens
50. Peptide inhibitors of transforming growth factor-β enhance the efficacy of antitumor immunotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.